Focus of the Week

August 22, 2019
Regeneron released positive phase 3 results for evinacumab, a drug for a rare form of deadly high cholesterol, and said it expects to seek FDA approval in 2020.
August 21, 2019
A new study shows a lack of racial and ethnic diversity in clinical trials for cancer drugs, highlighting issues currently being addressed by the FDA.
August 20, 2019
The neighborhood you live in not only impacts your health but also can predict if you’ll die prematurely, according to new research published in the journal Health & Place.
August 19, 2019
Interest in omega-3 fatty acids have increased since publication of the results of REDUCE-IT.
August 16, 2019
Health plans on the Affordable Care Act (ACA) exchanges will be required to display quality ratings starting with the 2020 plan year, according to an announcement from CMS, which is expanding the 5-star rating system it uses on Medicare plans to the health insurance exchanges.
August 15, 2019
The authors call for more personalized screening protocols to find cancer earlier in younger adults, as well as public health efforts to address obesity.
August 14, 2019
While air pollution has long been associated with cardiovascular and respiratory diseases, this is believed to be the first longitudinal study of air pollution and emphysema progression.
August 12, 2019
Using data from 330 millennials responding to an online survey in December 2018, a Welltok survey revealed that 78% of the age group feel that employers are not doing enough to support their well-being.
August 09, 2019
People who have better cardiovascular health, as scored by the American Heart Association's Life's Simple 7, at age 50 have a lower risk of developing dementia over the next 25 years, according to a new study.
August 08, 2019
Since the first call to action was published in 2015, there have been 18 firearm-related mass murders with 4 or more deaths, killing 288 people and injuring 703 more.
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.